UC given $1 million to develop skin cancer prevention treatment

A research team led by University of Cincinnati (UC) scientists has received $1 million from the National Cancer Institute to develop a new topical treatment that would not only increase skin pigmentation to block harmful ultraviolet (UV) rays, but also repair damage that can lead to skin cancer.

The researchers will work with a chemically modified hormone called alpha-melanocyte stimulating hormone (alpha-MSH). Known to increase skin pigmentation--the "tan" that reduces dangerous UV ray penetration--alpha-MSH has also been found to repair precancerous damage that UV rays do to skin cell DNA, the genetic material within cells.

"We hope to develop a new topical cream that will prevent skin cancer by both increasing skin pigmentation and at the same time repairing DNA damage caused by UV radiation," says study leader Zalfa Abdel-Malek, PhD, of UC's dermatology department.

"We have already shown that alpha-MSH repairs DNA damage caused by excessive sun exposure, thus reversing the cancer-causing effects of UV radiation," says Abdel-Malek, who has studied this phenomenon in isolated human melanocytes, the cells that produce the tanning pigment melanin.

Abdel-Malek will work with Ana Luisa Kadekaro, PhD, a UC dermatology instructor, to determine the ability of alpha-MSH, and synthesized versions of it, to reduce DNA damage in melanocytes that have been exposed to UV radiation in the lab.

To make it easier for the hormone to penetrate the fatty lipid layer of the skin, team members James Knittel, PhD, of UC's College of Pharmacy, and Carrie Haskell-Luevano, PhD, of the University of Florida, have already reduced alpha-MSH from its original peptide chain of 13 amino acids to a chain of only four amino acids. They hope to make the chain even smaller, and consequently more effective at penetrating the skin to target the melanocytes.

Dorothy Supp, PhD, of UC's department of surgery, will study the synthesized pe

Contact: Sheryl Hilton
University of Cincinnati

Page: 1 2

Related biology news :

1. St. Jude shows gene test not needed if cancer drug given in low doses
2. Anthropologist given one of nations top scientific honors
3. Novel approach to cancer drug given major boost
4. Drug can reduce severe bleeding in mothers who have just given birth
5. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
6. Once given no respect, cells tiny RNAS take drivers seat
7. Six research units given the go-ahead
8. US Department of Defense awards $1.6 million for implantable biochip research
9. Nottingham biosciences million pound injection
10. $9 million EPSCoR grant to foster integrated research
11. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards

Post Your Comments:

(Date:4/28/2020)... , ... April 27, 2020 , ... ... category-defining service was started by three teenagers with an idea to help millions ... world during the time of great need and suffering, an outlet has been ...
(Date:4/23/2020)... Wis. (PRWEB) , ... April 23, 2020 , ... ... its expansion and recruitment plans. MDG provides critical infrastructure products for the animal ... push MDG’s previous plans for expansion. Further, as supply channels from overseas competitors ...
(Date:4/22/2020)... Calif. (PRWEB) , ... April 21, 2020 , ... ... driving digital transformation and innovation in technology and compliance, announces a new managed ... a best-in-class trio of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... 13, 2020 , ... Early stages of drug discovery often ... information on the drug’s mechanism of action (MOA). Gene expression profiling technologies like ... activity of molecular pathways. This information can complement phenotypic readouts and can be ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ... company, announced today the launch of its iGlucose® LTE Cat-M Cellular ... solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity available, ...
(Date:4/22/2020)... BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) , ... ... ... headquartered in Budapest with US offices in Cambridge, MA, announced today that Omixon’s ... Meintjes led the early commercialisation of Omixon’s flagship product Holotype HLA since 2014 ...
(Date:4/7/2020)... ... 06, 2020 , ... Gateway Genomics , leading developer of direct-to-consumer genetic ... Gender DNA Tests sold in March, just months after attaining the 150,000-test landmark ... where a mom could order her kit online, collect a DNA sample from her ...
Breaking Biology Technology:
Cached News: